Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Lukoil reduced production but maintained oil exports

4/3/24 LKOH

Prepared Pre-IPO of a subsidiary of a major real estate developer

4/3/24 OTCI

Positive Technologies has entered a new market segment

4/3/24 POSI

M.Video-Eldorado opened 15 compact format stores

4/3/24 MVID

Astra will begin expansion into overseas markets in 2025

4/3/24 ASTR

Pharmacy Chain 36.6 summarized its results in 2023

4/3/24 APTK

Permenergosbyt reported for 2023 by RAS

4/3/24 PMSB

CarMoney reported for 2023 by IFRS

4/3/24 CARM

Astra may allocate 50% of its 2023 earnings to dividends

4/3/24 ASTR

Tinkoff Bank reported for 2023 by RAS

4/2/24 T